News

Clinical trials in Australia to use common voice

Posted: 9 June 2023 ARCS Australia has released a white paper to define common terms used in decentralised clinical trials providing a common and consistent language for the sector. The paper was released on day two of the…

Kinoxis awarded new US grant funding to support clinical development of KNX100 for opioid use disorder

Posted: 9 June 2023 Kinoxis Therapeutics is pleased to announce it has been awarded a UH3 grant by the National Institute on Drug Abuse (NIDA), part of the US National Institutes of Health (NIH), which is expected to…

CSIRO invests $25 million to drive biotech innovation

Posted: 9 June 2023 Australia’s national science agency, CSIRO, has invested $25 million up to 2027 in a new program that will harness the building blocks of life to solve intractable problems. Advanced Engineering Biology (AEB) is the latest…

Avecho completes development of TPM-enhanced cannabinoid gummies

Posted: 9 June 2023 Avecho Biotechnology Limited today announced it has completed the development of first generation TPM® gummies containing cannabinoids. TPM cannabinoid gummies out–perform standard products with faster onset and greater magnitude of effect.Gummies are chewable, jelly–like preparations made…

Optiscan on mission to revolutionise medical imaging

Posted: 9 June 2023 ASX-listed Optiscan Imaging is ramping up its bid to pioneer a new standard of care in digital pathology and precision surgery, with its biopsy-free, slide-free, non-invasive, live single-cell medical imaging technology. The company’s patented…

BioMelbourne Network and Wilam welcome CAI as foundational corporate partner

Posted: 8 June 2023               BioMelbourne Network’s digital transformation strategy is designed to change how our sector connects, strengthens and grows, to “reimagine engagement”. In November 2022, we launched Wilam, our Life…

Abstract & poster highlighting positive clinical results for ColoSTAT® Poster Presentation at ASCO Annual Meeting

Posted: 7 June 2023 Transformative cancer diagnostics technology company Rhythm Biosciences Ltd (ASX: RHY) (Rhythm or the Company) is pleased to announce that the abstract detailing the main results from the clinical trial for ColoSTAT®, its simple blood…

VIRALEZE Nasal Spray Approved in Malaysia

Posted: 6 June 2023 Starpharma today announces that it has achieved regulatory approval for its antiviral nasal spray product, VIRALEZE™, in Malaysia. The registration will allow Starpharma and its commercial partners to market and sell the product in Malaysia,…

Unlocking the Mystery of Brain Function and Connectivity

Posted: 5 June 2023 The science of this game-changing Monash-led research is complicated. But also, in the end, pretty simple. The shape of your brain is much more important than scientists have previously thought, learning now that how…

Peter Mac Scientists Discover Fundamental Breakthrough in Liver Cancer Development

Posted: 5 June 2023 New Peter Mac research recently published in Proceedings of the National Academy of Sciences (PNAS) has discovered a fundamental breakthrough related to the development of liver cancer The research team, led by Dr Andrew…

Improving Outcomes for Brain Cancer Patients

Posted: 5 June 2023 Despite our best research efforts, outcomes for most brain cancer have not improved significantly over the last 30 years but Dr Jim Whittle believes that is about to change. Dr Whittle, a medical oncologist…

Nasodine Phase 3 Clinical Trial Surpasses 80% Recruitment

Posted: 1 June 2023 Firebrick Pharma is pleased to provide an update on the progress of the confirmatory Phase 3 clinical trial of Nasodine Nasal Spray as a treatment for the common cold. The study, which commences in…

Home

News & opinion

Member Directory

Events